Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05818_nanopub.RAeEnSI3aVsOhlzcvN2xdztdQDA6J57QFNngitQUv3Mwo#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05818 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05818 label "SGN-15 [drugbank:DB05818]" assertion.
- drugbank:DB05818 seeAlso DB05818 assertion.
- drugbank:DB05818 description "SGN-15 is studied in the treatment of cancer. It combines a monoclonal antibody with the anticancer drug doxorubicin. Monoclonal antibodies are substances that are made in the laboratory and that can locate and bind to cancer cells. Doxorubicin is a type of anthracycline antitumor antibiotic. When it is combined with a monoclonal antibody, it forms a type of drug conjugate. Also called cBR96-doxorubicin immunoconjugate." assertion.
- drugbank:DB05818 identifier "drugbank:DB05818" assertion.
- drugbank:DB05818 title "SGN-15" assertion.
- drugbank:DB05818 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05818 drugbank_vocabulary:drugbank-id "DB05818" assertion.
- drugbank:DB05818 bio2rdf_vocabulary:x-identifiers.org DB05818 assertion.
- drugbank:DB05818 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05818" assertion.
- drugbank:DB05818 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05818 bio2rdf_vocabulary:identifier "DB05818" assertion.